Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling

Author:

Stencel Jason1,Alai Hamid R.12,Dhore-patil Aneesh1ORCID,Urina-Jassir Daniela1ORCID,Le Jemtel Thierry H.1

Affiliation:

1. Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, Tulane University Heart and Vascular Institute, New Orleans, LA 70112, USA

2. Southeast Louisiana VA Healthcare System (SLVHCS), New Orleans, LA 70119, USA

Abstract

Owing to the overwhelming obesity epidemic, preserved ejection fraction heart failure commonly ensues in patients with severe obesity and the obese phenotype of preserved ejection fraction heart failure is now commonplace in clinical practice. Severe obesity and preserved ejection fraction heart failure share congruent cardiovascular, immune, and renal derangements that make it difficult to ascertain whether the obese phenotype of preserved ejection fraction heart failure is the convergence of two highly prevalent conditions or severe obesity enables the development and progression of the syndrome of preserved ejection fraction heart failure. Nevertheless, the obese phenotype of preserved ejection fraction heart failure provides a unique opportunity to assess whether sustained and sizeable loss of excess body weight via metabolic bariatric surgery reverses the concentric left ventricular remodeling that patients with preserved ejection fraction heart failure commonly display.

Publisher

MDPI AG

Subject

General Medicine

Reference216 articles.

1. Hales, C.M., Carroll, M.D., Fryar, C.D., and Ogden, C.L. (2020). Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017–2018, CDC National Center for Health Statistics.

2. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity;Ward;N. Engl. J. Med.,2019

3. Obesity and severe obesity forecasts through 2030;Finkelstein;Am. J. Prev. Med.,2012

4. Bariatric Surgery and Cardiovascular Outcomes in Patients with Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study;Doumouras;Circulation,2021

5. PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: Rationale and design;Redfield;Circ. Heart Fail.,2012

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3